abagovomab 33
abciximab 24
abituzumab 24
abrilumab 13
actoxumab 13
adalimumab 15
aducanumab 14
afasevikumab 12
alacizumab_pegol 8
alemtuzumab 27
alirocumab 18
amatuximab 38
andecaliximab 22
anifrolumab 18
anrukinzumab 17
aprutumab 17
aprutumab_ixadotin 17
arcitumomab 17
ascrinvacumab 4
atezolizumab 14
atinumab 15
avelumab 9
basiliximab 28
bavituximab 30
begelomab 26
benralizumab 26
bevacizumab_beta 22
bezlotoxumab 13
bimagrumab 15
bleselumab 18
blinatumomab 32
blosozumab 30
bococizumab 18
brazikumab 19
brentuximab_vedotin 22
briakinumab 20
brodalumab 10
brolucizumab 28
brontictuzumab 26
burosumab 20
cabiralizumab 27
camrelizumab 15
canakinumab 23
cantuzumab_ravtansin 37
carlumab 16
carotuximab 13
cergutuzumab_amunaleukin2 26
cergutuzumab_amunaleukin 26
certolizumab_pegol 27
cetiximab 37
citatuzumab_bogatox 28
cixutumumab 25
clivatuzumab_tetraxetan 21
codrituzumab 22
conatumumab 14
concizumab 18
crenezumab 19
crizanlizumab 23
crotedumab 20
dacetuzumab 22
daclizumab 16
dalotuzumab 27
dapirolizumab_pegol 26
daratumumab 13
dectrekumab 11
demcizumab 22
denosumab 8
depatuxizumab 19
depatuxizumab_mafodotin 19
dezamizumab 23
dinutuximab 31
diridavumab 22
domagrozumab 17
drozitumab 16
duligotuzumab 20
durvalumab 15
dusigitumab 21
efalizumab 37
efungumab 23
eldelumab 17
elezanumab 20
elgemtumab 10
elotuzumab 16
emactuzumab 17
emapalumab 25
emibetuzumab 19
enavatuzumab 25
enfortumab_vedotin 14
enoblituzumab 19
enokizumab 26
enoticumab 20
ensituximab 29
eptinezumab 15
erenumab 22
etaracizumab 14
etrolizumab 23
evinacumab 22
evolocumab 16
farletuzumab 3
fasinumab 17
fezakinumab 22
fibatuzumab 9
ficlatuzumab 25
firivumab 25
flanvotumab 18
fletikumab 24
foralumab 15
foravirumab 17
fremanezumab 30
fresolimumab 16
fulranumab 22
futuximab 18
galcanezumab 15
ganitumab 20
gantenerumab 14
gemetuzumab 29
gemtuzumab2 23
gemtuzumab 23
gevokizumab 21
girentuximab 27
glembatumumab 18
glembatumumab_vedotin 18
guselkumab 20
ibalizumab 29
ibritumomab 22
icrucumab 14
idarucizumab 24
ifabotuzumab 9
imalumab 15
imgatuzumab 22
inclacumab 23
indatuximab_ravtansin 25
indusatumab 18
inebilizumab 22
intetumumab 14
iodine_girentuximab 31
ipilimumab 5
iratumumab 11
isatuximab 33
itolizumab 23
ixekizumab 26
labetuzumab_govitecan 25
lambrolizumab 28
lampalizumab 25
lanadelumab 19
landogrozumab 15
laprituximab 31
lebrikizumab 30
lendalizumab 25
lenzilumab 18
lifastuzumab_vedotin 25
ligelizumab 23
lilotomab 30
lirilumab 23
lodelcizumab 16
lokivetmab 16
lorvotuzumab_mertansin 18
lucatumumab 30
lumretuzumab 19
lupartumab 19
lutikizumab 16
margetuximab 31
milatuzumab 28
mirvetuximab 35
mirvetuximab_soravtansin 35
modotuximab 40
mogamulizumab 22
monalizumab 19
motavizumab 31
moxetumomab_pasudotox 19
namilumab 20
naratuximab 30
naratuximab_emtansin 30
narnatumab 19
navicixizumab2 28
navicixizumab 24
navivumab 30
necitumumab 10
nemolizumab 27
nesvacumab 14
nivolumab 13
obiltoxaximab 21
obinutuzumab 30
ocaratuzumab 21
ofatumumab 15
olaratumab 17
olokizumab 24
omalizumab 18
onartuzumab 23
ontuxizumab 28
opicinumab 14
orticumab 12
otelixizumab 39
oxelumab 11
ozanezumab 25
pamrevlumab 12
panobacumab 19
parsatuzumab 31
pasotuxizumab 17
pateclizumab 16
patritumab 19
pembrolizumab 28
perakizumab 22
pidilizumab 15
pinatuzumab_vedotin 16
plozalizumab 23
pogalizumab 25
polatuzumab_vedotin 20
ponezumab 27
prezalumab 15
pritoxaximab 35
quilizumab 19
racotumomab 29
radretumab 17
ralpancizumab 23
ramucirumab 12
ranevetmab 29
ranibizumab 21
refanezumab 24
remtolumab 19
rilotumumab 14
rinucumab 16
risankizumab 32
rituximab 19
rivabazumab 23
robatumumab 20
roledumab 30
romosozumab 22
rontalizumab 23
rosmantuzumab 23
rozanolixizumab 22
sacituzumab 27
sacituzumab_govitecan 27
samalizumab 25
sapelizumab 22
sarilumab 17
secukinumab 17
seribantumab 15
setoxaximab 33
sifalimumab 10
siltuximab 22
simtuzumab 26
sirukumab 9
solanezumab 28
solitomab 23
stamulumab 16
suptavumab 23
suvizumab 15
tabalumab 21
tadocizumab 18
tamtuvetmab 30
tanezumab 22
tarextumab 11
tavolixizumab 12
telisotuzumab 31
teplizumab 19
tesidolumab 22
tezepelumab 24
tigatuzumab 16
tildrakizumab 21
timolumab 16
tisotumab 11
tosatoxumab 30
tositumomab 19
tralokinumab 31
trastuzumab 24
tregalizumab 21
trevogrumab 12
ublituximab 16
urelumab 15
ustekinumab 27
utomilumab 21
vadastuximab 26
vadastuximab_talirin 26
vandortuzumab_vedotin 22
vantictumab 19
vanucizumab2 22
vanucizumab 31
varlilumab 18
vatelizumab 22
vedolizumab 24
veltuzumab 10
vesencumab 10
vorsetuzumab 22
vorsetuzumab_mafodotin 22
vunakizumab 31
xentuzumab 19
zatuximab 40
